Clinical trial Recruiting at 1 site Interventional Ages 5 to 17

Using electrical stimulation to treat bedwetting in children

Official title: Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Nocturnal Enuresis in Children

Run by Albany Medical College · NCT06135311 · Data updated 2026-11-12

This study is testing if a new electrical stimulation treatment can help children aged 5-17 who struggle with bedwetting after other methods haven't worked.

Quick facts

Study typeInterventional
Ages5 Years to 17 Years
SexAll
Enrollment70 (estimated)
SponsorAlbany Medical College
Academic / other
Locations1 site (Albany, New York)
StatusRecruiting
StartedOctober 24, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 2, 2025
Trial IDNCT06135311 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 5-17 with nocturnal enuresis who have failed initial behavioral modification treatments.

Probably not a fit

Patients with daytime incontinence, those who have recently tried other treatments for bedwetting, or those with certain medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial involves children aged 5-17 who are experiencing primary nocturnal enuresis and have not responded to behavioral modifications. Participants will be randomized into two groups to receive transcutaneous electrical nerve stimulation (TENS) with different pulse widths: one group at 260 microseconds and the other at 50 microseconds. The TENS unit will be applied nightly for 30 minutes over a period of 30 days, with caregivers instructed on its use. The effectiveness of the treatment will be monitored through diaries documenting nighttime incontinence.

Why it matters

Potential benefit: If successful, this approach could provide an effective non-pharmacological treatment option for children suffering from bedwetting.

How similar studies have gone: While the use of TENS for nocturnal enuresis is a novel approach, similar neuromodulation techniques have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Presenting with nocturnal enuresis (more than 1x a week)
2. Failed Behavioral modification treatment (limiting evening drinking, double voiding prior to bedtime, bowel habits, social anxiety factors) during the 30 day period prior to randomization
3. Ability to provide informed consent and assent and complete study requirements

Exclusion Criteria:

1. Patients who have previously tried pharmacologic treatment for nocturnal enuresis, neuromodulation or other alternative therapy for urologic disorders within the past 30 days
2. Daytime incontinence symptoms
3. Known "high volume" voiders (determined from history)
4. Bedwetting episodes on the average of less than two times per week,
5. Medications predisposing to incontinence (eg, Lithium for bipolar disorder)
6. Other known voiding or neurologic disorders (eg, overactive bladder, myelomeningocele, interstitial cystitis, etc)
7. Secondary etiologies for nocturnal enuresis (eg, cystitis, obstructive sleep apnea, urinary fistulae, heart disease)
8. Any contraindications to usage of a TENS unit (pacemaker or other implantable device, lymphedema, pregnancy, malignancy, bleeding or clotting disorders, unhealthy tissue, seizure disorders, impaired cognition)
9. Any history of heart disease or complications

Where it's running

  • Albany Medical College
    Albany, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Adam Howe, MD — Albany Medical College
  • Study coordinator: Brenda Romeo, CCRC
  • Email: romeob@amc.edu
  • Phone: 518-262-3349

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.